- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01318798
Development and Validation of an Enhanced Prediction Score for Postoperative Acute Renal Failure After Liver Resection
Development and Validation of an Enhanced Prediction Score for Post-operative Acute Renal Failure Following Liver Resection
Study Overview
Status
Conditions
Detailed Description
To enhance and validate an already pre-existing score accurately predicting post-operative acute renal failure (ARF) after hepatic surgery
We will enhance a pre-existing score predicting ARF based on pre-operative as well as intra-operative predictors.
Development process: we will identify the strongest predictors of ARF in a multivariable logistic regression model followed by a stepwise backward logistic regression analysis and bootstrapping.
Validation process: we will perform an internal validation by calibrating the prediction model as well as by k-fold cross validation (c statistics) and bootstrapping. Additionally, we will calculate the discrimination by the area under the curve (AUC).
Decision curve analysis: Furthermore we will perform a decision curve analysis to evaluate the clinical consequences of both prediction scores whether a patient with increased ARF risk would post-operative benefit of a treatment on the ICU.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Zurich, Switzerland, 8091
- University Hospital of Zurich, Departmente of Visceral and Transplantation Surgery
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- > 18 years
- scheduled for liver surgery
- benign as well as malignant diseases
Exclusion Criteria:
- liver trauma
- incomplete data sets
- pre-operative chronic renal failure requiring hemodialysis
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Patients with post-operative ARF
Patients developing acute renal failure (ARF) following liver surgery ARF was defined according to the RIFLE criteria as an absolute increase in serum-creatinine of more than 0.3 mg/dl above baseline, or an increase of more than 1.5 times the pre-operative baseline value within 48 hours after surgery, or a reduction of urinary output less than 0.5 ml/kg/h for at least 6 hrs. |
Patients without post-operative ARF
Patients with normal kidney function (without acute renal failure (ARF)) following liver surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Development of an enhanced prediction score for ARF
Time Frame: within 48 hours post-operative
|
Development of an enhanced but still simple and easy applicable score based on pre- and extended by intra-operative risk factors to predict postoperative ARF in patients scheduled for liver resection
|
within 48 hours post-operative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Decision curve analysis
Time Frame: within 48 hours post-operative
|
Describing a decision making model by performing a decision curve analysis for clinical consequences of the enhanced prediction score and comparing it with the pre-operative prediction score
|
within 48 hours post-operative
|
internal validation of the enhanced prediction score
Time Frame: within 48 hours post-operative
|
internal Validation: discrimination, calibration, k-fold cross validation and bootstrapping
|
within 48 hours post-operative
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ksenija Slankamenac, med. pract., University Hospital Zurich, Visceral and Transplantation Surgery
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- StV 33-2009
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Renal Failure
-
University Hospital, Clermont-FerrandRecruitingAcute Kidney Injury | Transient Acute Renal Failure | Persistent Acute Renal FailureFrance
-
University of WashingtonJohns Hopkins University; National Institute of Diabetes and Digestive and... and other collaboratorsRecruitingChronic Kidney Diseases | Acute Renal Failure | Acute Renal Injury | Acute Kidney Failure | Chronic Renal Insufficiency | Kidney Failure, Acute | Renal Insufficiency, Acute | Acute Renal Insufficiency | Acute Kidney Insufficiency | Renal Failure, Acute | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney... and other conditionsUnited States
-
Wake Forest University Health SciencesCompletedRenal Replacement Therapy | Kidney Failure, AcuteUnited States
-
University Hospital, GhentCompletedAcute Renal Failure | Chronic Renal FailureBelgium
-
Washington University School of MedicineCompletedAcute Renal Failure | Chronic Renal FailureUnited States
-
University Hospital, GrenobleRecruitingRenal Insufficiency | Renal Failure | Acute Renal Failure | Acute Renal InsufficiencyFrance
-
InCor Heart InstituteUnknownAcute Kidney Injury | Acute Renal Failure | Acute Renal InjuryBrazil, Spain
-
Angiodynamics, Inc.TerminatedChronic Kidney Disease | Acute Kidney Injury | Acute Renal Failure | Renal Failure Chronic Contrast InducedUnited States
-
RenaMed BiologicsTerminatedKidney Failure, AcuteUnited States
-
University of AlbertaAlberta Heritage Foundation for Medical ResearchCompletedAcute Renal Failure | Chronic Renal Failure | Contrast-induced NephropathyCanada